2,396
Views
4
CrossRef citations to date
0
Altmetric
Neurology

Modelling the value of innovative treatments for Alzheimer’s disease in the United States

, , &
Pages 764-769 | Received 04 Mar 2021, Accepted 05 May 2021, Published online: 04 Jun 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.